Insmed
INSM | NASDAQ
$120.02
-$0.98 (-0.81%)
Sep 22, 2026, 11:48 AM ET · Market open
Market Data
Market Cap $26.23B
Enterprise Value $25.1B
Beta 0.82
Average Volume 3.5M
Shares Outstanding (Diluted) 217.35M
Shares Change YoY 14.82%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US4576693075
Price Performance
Price Change 1M -3.6%
Price Change 3M 18.4%
Price Change 6M -18.4%
Price Change YTD -31.7%
Price Change 1Y -16.6%
Price Change 3Y 362.4%
Price Change 5Y 348.0%
1M CAGR (ann.) -7.7%
1Y CAGR (ann.) -17.0%
5Y CAGR (ann.) 34.3%
All-Time CAGR 11.9%
Valuation
PE Ratio -29.44
Forward PE 138.00
PEG Ratio -1.17
Forward PEG 0.19
PS Ratio 23.05
Forward PS 9.10
PB Ratio 34.62
P/FCF Ratio -24.65
P/Adj. FCF Ratio -21.36
P/OCF Ratio -33.80
EV/Sales 22.07
EV/EBIT -31.76
EV/EBITDA -32.60
EV/FCF -23.60
Earnings Yield -3.4%
FCF Yield -4.1%
Adj. FCF Yield -4.7%
Financial Health
Net Cash $1.12B
Total Debt $36.37M
Cash & Short-Term Investments $1.16B
Total Assets $2.1B
Current Ratio 3.72
Quick Ratio 3.40
Debt / Equity Ratio 0.77
Debt / EBITDA -0.05
Debt / FCF -0.03
OCF / Debt -27.54
Interest Coverage -10.05
Altman Z-Score 7.81
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 83.3%
Operating Profit Margin -71.9%
EBITDA Margin -67.7%
Net Profit Margin -76.9%
FCF Margin -93.5%
Adj. FCF Margin -108.0%
SBC / Revenue 10.4%
SBC Impact (per share) -15.4%
Returns
Return on Assets -41.6%
Return on Equity -111.3%
Return on Invested Capital -48.9%
Return on Capital Employed -49.1%
Return on Tangible Assets -46.7%
Historical Growth (CAGR)
Revenue CAGR 3Y 61.6%
Revenue CAGR 5Y 46.1%
Revenue CAGR 10Y 32.4%
EPS CAGR 3Y 12.6%
EPS CAGR 5Y -3.5%
EPS CAGR 10Y -5.9%
FCF CAGR 3Y -28.1%
FCF CAGR 5Y -26.3%
FCF CAGR 10Y -19.4%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 35
EPS Growth Next 3Y 91.0%
Revenue Growth Next 3Y 64.3%
Earnings Date Oct 28, 2026
EPS Estimate (next Q) -$0.37
EPS Growth Est (next Q) -78.9%
Revenue Est (next Q) $501.23M
Revenue Growth Est (next Q) 252.1%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $196.93
Price Target Upside 62.8%
Cash Flow
Operating Cash Flow $-1B
Free Cash Flow $-1.06B
Adj. Free Cash Flow $-1.23B
FCF Per Share -$3.85
OCF Per Share -$3.58
OCF/S Ratio -68.5%
Income Statement
Revenue $1.14B
Gross Profit $947.34M
Operating Income $-817.54M
EBITDA $-769.98M
Net Income $-875.31M
EPS (Diluted) -$4.11
Revenue / Employee $683.67K
Profit / Employee $-526.03K
Employees 1,664
Add to Watchlist
Select watchlists to add or remove INSM